Tirzepatide Frequently Asked Questions
US$ 24.46
glp 1 drugs and addiction IUPHAR review – Glucagon-like peptide-1 (GLP-1) substance use disorders: An emerging pharmacotherapeutic target GLP-1s like Ozempic transformed weight
Description
M., Waheed H
Hinnen DA
doi: 10.1186/s40478-021-01180-z [DOI] [PMC free article] [PubMed] [Google Scholar] 229
However, GLP-1 RAs may be considered to lower the CV risk in patients with T2D who have a high to very high risk of CVD, (class IIb, level C)
doi: 10.1038/sj.bjp.0705453
